Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1980844 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2MAPK1CYP1A2 | |
| SCHEMBL5317333 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| SCHEMBL9632303 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| SCHEMBL200399 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| SCHEMBL5319042 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| SCHEMBL200766 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| SCHEMBL198090 | 0.92 | CES2 (0.52) | MAPTCES2MAPK1CYP1A2MEN1 | |
| Hydrochloric Acid SCHEMBL16990768 | 0.90 | CES2 (0.50) | MAPTCES2MAPK1CYP1A2MEN1 | |
| Hydrochloric Acid SCHEMBL9632302 | 0.90 | CES2 (0.50) | MAPTCES2MAPK1CYP1A2MEN1 | |
| Hydrochloric Acid SCHEMBL7561213 | 0.90 | CES2 (0.50) | MAPTCES2MAPK1CYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-11246873-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-02-15 | — | — | US | disclosed |
| US-20200390780-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2020-12-17 | — | — | US | disclosed |
| US-10660899-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-05-26 | — | — | US | disclosed |
| US-20170136029-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | IRM LLC (BM) | 2017-05-18 | — | — | US | disclosed |
| US-9592288-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-03-14 | — | — | US | disclosed |
| US-20160166687-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | THE SCRIPPS RESEARCH INSTITUTE | 2016-06-16 | — | — | US | disclosed |
| US-20140038949-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | IRM LLC (BM) | 2014-02-06 | — | — | US | disclosed |
| EP-2675893-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | The Scripps Research Institute (US) | 2013-12-25 | — | — | EP | disclosed |
| WO-2012112933-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-08-23 | — | — | WO | disclosed |
| WO-2005079204-A2 | ARTIFICIAL SYNAPSE CHIP | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2005-09-01 | — | — | WO | disclosed |
| WO-2004110364-A9 | THIOTUNGSTATE ANALOGUES AND USES THEREOF | ATTENUON L L C (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2004110364-A2 | THIOTUNGSTATE ANALOGUES AND USES THEREOF | ATTENUON L.L.C. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040224002-A1 | Artificial synapse chip | VISX, INCORPORATED | 2004-11-11 | — | — | US | disclosed |
| US-20040192594-A1 | Modified neurotoxins as therapeutic agents for the treatment of diseases and methods of making | REID, PH.D., PAUL | 2004-09-30 | — | — | US | disclosed |
| EP-1421172-A2 | ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-05-26 | — | — | EP | disclosed |
| US-20030032946-A1 | Artificial synapse chip interface for electronic prosthetic retina | VISX, INCORPORATED | 2003-02-13 | — | — | US | disclosed |
| WO-2003002710-A2 | ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA | THE BOARD OF TRUSTEES OF LELAND STANFORD JR. UNIVERSITY (US) | 2003-01-09 | — | — | WO | disclosed |
| EP-0572529-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1993-12-08 | — | — | EP | disclosed |